Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
Repligen Corporation announced its planned participation at the Wells Fargo 21st Annual Healthcare Conference, where its CEO and CFO will engage in an analyst-led discussion. The company continues to emphasize its role in developing innovative bioprocessing technologies primarily for biopharmaceutical developers and CDMOs.